Krystal Biotech is a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases
Krystal Biotech is a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases. The company’s first commercial product, VYJUVEK®, is the first and only redosable gene therapy for the treatment of dystrophic epidermolysis bullosa.